Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7778-42-9

Post Buying Request

7778-42-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7778-42-9 Usage

Uses

Sulfamoyl chloride is Used for the preparation of substituted glycoside sulfamates as anticonvulsant agents for the treatment of epilepsy.

Check Digit Verification of cas no

The CAS Registry Mumber 7778-42-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,7,7 and 8 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 7778-42:
(6*7)+(5*7)+(4*7)+(3*8)+(2*4)+(1*2)=139
139 % 10 = 9
So 7778-42-9 is a valid CAS Registry Number.
InChI:InChI=1/ClH2NO2S/c1-5(2,3)4/h(H2,2,3,4)

7778-42-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Chlorosulfonamide

1.2 Other means of identification

Product number -
Other names sulfamoyl chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7778-42-9 SDS

7778-42-9Synthetic route

isocyanate de chlorosulfonyle
1189-71-5

isocyanate de chlorosulfonyle

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

Conditions
ConditionsYield
With formic acid at 0 - 20℃; for 1h;100%
With formic acid In dichloromethane at 0 - 20℃; for 12h; Schlenk technique;97%
With formic acid at 5 - 40℃; Inert atmosphere;96%
formic acid
64-18-6

formic acid

isocyanate de chlorosulfonyle
1189-71-5

isocyanate de chlorosulfonyle

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

Conditions
ConditionsYield
In toluene at 23℃; for 10h; Inert atmosphere;100%
In dichloromethane at 0 - 22℃; for 12h; Inert atmosphere; Schlenk technique;97%
at 5 - 20℃;92%
isocyanate de chlorosulfonyle
1189-71-5

isocyanate de chlorosulfonyle

water
7732-18-5

water

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

Conditions
ConditionsYield
In tetrahydrofuran at -20 - 0℃;
In tetrahydrofuran at -20 - 0℃;
sodium phenylsulfamate
15790-84-8

sodium phenylsulfamate

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

Conditions
ConditionsYield
With chlorosulfonic acid; triethanolamine; phosphorus pentachloride; aniline In NaOH; ethanol; chloroform; benzene
N-(1-(3-amino-2-cyanophenoxy)-2-methylpropan-2-yl)butyramide
1093206-32-6

N-(1-(3-amino-2-cyanophenoxy)-2-methylpropan-2-yl)butyramide

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

N-(1-(3-sulfamoylamino-2-cyanophenoxy)-2-methylpropan-2-yl)butyramide
1093206-31-5

N-(1-(3-sulfamoylamino-2-cyanophenoxy)-2-methylpropan-2-yl)butyramide

Conditions
ConditionsYield
100%
1-(1-(3-amino-2-cyanophenoxy)-2-methylpropan-2-yl)-3-ethylurea
1093206-35-9

1-(1-(3-amino-2-cyanophenoxy)-2-methylpropan-2-yl)-3-ethylurea

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

1-(1-(3-sulfamoylamino-2-cyanophenoxy)-2-methylpropan-2-yl)-3-ethylurea
1093206-34-8

1-(1-(3-sulfamoylamino-2-cyanophenoxy)-2-methylpropan-2-yl)-3-ethylurea

Conditions
ConditionsYield
100%
N-(4-(3-amino-2-cyanophenoxy)butyl)acetamide
1093206-49-5

N-(4-(3-amino-2-cyanophenoxy)butyl)acetamide

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

N-(4-(2-cyano-3-(sulfamoylamino)phenoxy)butyl)acetamide
1093206-48-4

N-(4-(2-cyano-3-(sulfamoylamino)phenoxy)butyl)acetamide

Conditions
ConditionsYield
100%
1-(3-(3-amino-2-cyanophenoxy)-2,2-dimethylpropyl)-3-(4-methoxybenzyl)urea
1093206-90-6

1-(3-(3-amino-2-cyanophenoxy)-2,2-dimethylpropyl)-3-(4-methoxybenzyl)urea

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

1-(3-(3-sulfamoylamino-2-cyanophenoxy)-2,2-dimethylpropyl)-3-(4-methoxybenzyl)urea
1093206-89-3

1-(3-(3-sulfamoylamino-2-cyanophenoxy)-2,2-dimethylpropyl)-3-(4-methoxybenzyl)urea

Conditions
ConditionsYield
100%
tert-Butyl N-hydroxycarbamate
36016-38-3

tert-Butyl N-hydroxycarbamate

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

BocNHOSO2NH2
1310054-47-7

BocNHOSO2NH2

Conditions
ConditionsYield
In N,N-dimethyl acetamide at 0 - 20℃; for 2h; Inert atmosphere;100%
hydrogen fluoride
7664-39-3

hydrogen fluoride

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

germanium tetrafluoride
7783-58-6

germanium tetrafluoride

2ClH2NO2S*2H(1+)*F6Ge(2-)

2ClH2NO2S*2H(1+)*F6Ge(2-)

Conditions
ConditionsYield
at -196 - -40℃; for 72h; Schlenk technique;100%
hydrogen fluoride
7664-39-3

hydrogen fluoride

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

arsenic pentafluoride
7784-36-3

arsenic pentafluoride

ClH2NO2S*H(1+)*AsF6(1-)

ClH2NO2S*H(1+)*AsF6(1-)

Conditions
ConditionsYield
at -196 - -40℃; for 72h; Schlenk technique;100%
N6-(prop-2

N6-(prop-2"-ynyl)-2',3'-(O-isopropylidene)adenosine

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

C16H20N6O6S

C16H20N6O6S

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 0 - 20℃; for 1h;98%
1-sulfamoyloxymethyl-12-(3-ethyl-4-hydroxyphenyl)-12-dicarba-closo-dodecaborane

1-sulfamoyloxymethyl-12-(3-ethyl-4-hydroxyphenyl)-12-dicarba-closo-dodecaborane

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

1-sulfamoyloxymethyl-12-(3-ethyl-4-sulfamoyloxyphenyl)-1,12-dicarba-closo-dodecaborane

1-sulfamoyloxymethyl-12-(3-ethyl-4-sulfamoyloxyphenyl)-1,12-dicarba-closo-dodecaborane

Conditions
ConditionsYield
In N,N-dimethyl acetamide at 20℃; for 7h;97%
17-(N-Butylcarbamoyl)-3-(hydroxy)estra-1,3,5(10),16-tetraene
284045-28-9

17-(N-Butylcarbamoyl)-3-(hydroxy)estra-1,3,5(10),16-tetraene

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

17-(N-Butylcarbamoyl)-estra-1,3,5(10),16-tetraene-3-yl sulfamate
284045-29-0

17-(N-Butylcarbamoyl)-estra-1,3,5(10),16-tetraene-3-yl sulfamate

Conditions
ConditionsYield
With sodium hydrogencarbonate In N,N-dimethyl-formamide96%
3-hexyn-1-ol
1002-28-4

3-hexyn-1-ol

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

hex-3-yn-1-yl sulfamate

hex-3-yn-1-yl sulfamate

Conditions
ConditionsYield
With 2,6-dimethylpyridine; formic acid In N,N-dimethyl acetamide; acetonitrile at 0 - 25℃; for 3.5h; Inert atmosphere;96%
(±)-2-(3-bromo-4,5-dimethoxybenzyl)-6-hydroxy-7-methoxy-3-methyl-1,2,3,4-tetrahydroisoquinoline
1623785-56-7

(±)-2-(3-bromo-4,5-dimethoxybenzyl)-6-hydroxy-7-methoxy-3-methyl-1,2,3,4-tetrahydroisoquinoline

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

(±)-2-(3′-bromo-4′,5′-dimethoxybenzyl)-7-methoxy-3-methyl-6-sulfamoyloxy-1,2,3,4-tetrahydroisoquinoline
1623785-62-5

(±)-2-(3′-bromo-4′,5′-dimethoxybenzyl)-7-methoxy-3-methyl-6-sulfamoyloxy-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
With N,N-dimethyl acetamide In toluene at 0 - 25℃; for 2h;96%
[4-[(1R)-7-chloroisochroman-1-yl]-5-methyl-2-thienyl]-[4-[[(1R,3R,4S)-3-(hydroxymethyl)-4-triisopropylsilyloxy-cyclopentyl]amino]pyrimidin-5-yl]methanone

[4-[(1R)-7-chloroisochroman-1-yl]-5-methyl-2-thienyl]-[4-[[(1R,3R,4S)-3-(hydroxymethyl)-4-triisopropylsilyloxy-cyclopentyl]amino]pyrimidin-5-yl]methanone

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

[(1R,2S,4R)-4-{[5-({4-[(1R)-7-chloro-3,4-dihydro-1H-isochromen-1-yl]-5-methyl-2-thienyl}carbonyl)pyrimidin-4-yl]amino}-2-hydroxycyclopentyl]methyl sulfamate

[(1R,2S,4R)-4-{[5-({4-[(1R)-7-chloro-3,4-dihydro-1H-isochromen-1-yl]-5-methyl-2-thienyl}carbonyl)pyrimidin-4-yl]amino}-2-hydroxycyclopentyl]methyl sulfamate

Conditions
ConditionsYield
Stage #1: [4-[(1R)-7-chloroisochroman-1-yl]-5-methyl-2-thienyl]-[4-[[(1R,3R,4S)-3-(hydroxymethyl)-4-triisopropylsilyloxy-cyclopentyl]amino]pyrimidin-5-yl]methanone; sulphamoyl chloride With triethylamine In N,N-dimethyl-formamide at 20℃; for 1h;
Stage #2: With hydrogenchloride In water; N,N-dimethyl-formamide at 20℃; for 2h;
96%
(R)-3-carbamoyl-2-phenyl propanol

(R)-3-carbamoyl-2-phenyl propanol

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

N-ethyl-N,N-diisopropylamine
7087-68-5

N-ethyl-N,N-diisopropylamine

(S)-3-carbamoyl-2-phenyl propanol sulfamate

(S)-3-carbamoyl-2-phenyl propanol sulfamate

Conditions
ConditionsYield
In hexane; water; ethyl acetate; acetonitrile93%
In hexane; water; ethyl acetate; acetonitrile93%
tert-butyl (2-hydroxyphenyl)(oxo)acetate
1193444-97-1

tert-butyl (2-hydroxyphenyl)(oxo)acetate

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

C12H13NO5S

C12H13NO5S

Conditions
ConditionsYield
With formic acid In N,N-dimethyl acetamide; acetonitrile at 0 - 50℃; Schlenk technique; Inert atmosphere;93%
sulphamoyl chloride
7778-42-9

sulphamoyl chloride

(1S,2S,5S)-(-)-myrtanol
53369-17-8

(1S,2S,5S)-(-)-myrtanol

[(1S,2S,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-yl]methyl-sulfamate
1145767-51-6

[(1S,2S,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-yl]methyl-sulfamate

Conditions
ConditionsYield
In N,N-dimethyl acetamide at 0 - 20℃; for 3h;92%
N6-cyclopropyl-2',3'-O-isopropylidene-2-phenyladenosine
1082863-28-2

N6-cyclopropyl-2',3'-O-isopropylidene-2-phenyladenosine

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

N6-cyclopropyl-2',3'-O-isopropylidene-2-phenyl-5'-O-(sulfamoyl)adenosine
1082863-30-6

N6-cyclopropyl-2',3'-O-isopropylidene-2-phenyl-5'-O-(sulfamoyl)adenosine

Conditions
ConditionsYield
In N,N-dimethyl acetamide at 0℃; for 4h; Inert atmosphere;92%
[5-chloro-4-(methoxymethyl)-2-thienyl][4-({(1R,3R,4S)-3-(hydroxymethyl)-4-[(triisopropylsilyl)oxy]cyclopentyl}amino)pyrimidin-5-yl]methanone

[5-chloro-4-(methoxymethyl)-2-thienyl][4-({(1R,3R,4S)-3-(hydroxymethyl)-4-[(triisopropylsilyl)oxy]cyclopentyl}amino)pyrimidin-5-yl]methanone

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

{(1R,2S,4R)-4-[(5-{[5-chloro-4-(methoxymethyl)-2-thienyl]carbonyl}pyrimidin-4-yl)amino]-2-hydroxycyclopentyl}methyl sulfamate

{(1R,2S,4R)-4-[(5-{[5-chloro-4-(methoxymethyl)-2-thienyl]carbonyl}pyrimidin-4-yl)amino]-2-hydroxycyclopentyl}methyl sulfamate

Conditions
ConditionsYield
Stage #1: [5-chloro-4-(methoxymethyl)-2-thienyl][4-({(1R,3R,4S)-3-(hydroxymethyl)-4-[(triisopropylsilyl)oxy]cyclopentyl}amino)pyrimidin-5-yl]methanone; sulphamoyl chloride With triethylamine In dichloromethane; N,N-dimethyl-formamide at 0℃; for 0.5h;
Stage #2: With hydrogenchloride In dichloromethane; water; N,N-dimethyl-formamide at 0 - 20℃; for 3h;
90%
8-hydroxy-12a-methyl-3,4,4a,4b,5,6,10b,11,12,12a-decahydronaphtho[2,1-f]quinolin-2(1H)-one
1616-20-2

8-hydroxy-12a-methyl-3,4,4a,4b,5,6,10b,11,12,12a-decahydronaphtho[2,1-f]quinolin-2(1H)-one

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

3-O-sulphamyl-13α-amino-13,17-seco-1,3,5(10)-estratrien-17-oic-13,17-lactam
205118-80-5

3-O-sulphamyl-13α-amino-13,17-seco-1,3,5(10)-estratrien-17-oic-13,17-lactam

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide; mineral oil at 23℃; for 18.5h; Inert atmosphere;90%
(E)-3-(4-hydroxyphenyl)-N-nonylacrylamide

(E)-3-(4-hydroxyphenyl)-N-nonylacrylamide

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

C18H28N2O4S
501333-21-7

C18H28N2O4S

Conditions
ConditionsYield
In ISOPROPYLAMIDE at 20℃; for 1h;89%
(S)-3-carbamoyl-2-phenyl propanol

(S)-3-carbamoyl-2-phenyl propanol

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

N-ethyl-N,N-diisopropylamine
7087-68-5

N-ethyl-N,N-diisopropylamine

(R)-3-Carbamoyl-2-phenyl propanol sulfamate

(R)-3-Carbamoyl-2-phenyl propanol sulfamate

Conditions
ConditionsYield
In hexane; water; ethyl acetate; acetonitrile89%
In hexane; water; ethyl acetate; acetonitrile89%
(S)-3-N-methylcarbamoyl-2-(m-chlorophenyl)propanol

(S)-3-N-methylcarbamoyl-2-(m-chlorophenyl)propanol

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

N-ethyl-N,N-diisopropylamine
7087-68-5

N-ethyl-N,N-diisopropylamine

(R)-3-N-methylcarbamoyl-2-(m-chlorophenyl)propanol sulfamate

(R)-3-N-methylcarbamoyl-2-(m-chlorophenyl)propanol sulfamate

Conditions
ConditionsYield
In hexane; water; ethyl acetate; acetonitrile89%
3-N-methylcarbamoyl-2-(o-chlorophenyl)propanol

3-N-methylcarbamoyl-2-(o-chlorophenyl)propanol

diethyl ether
60-29-7

diethyl ether

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

3-N-methylcarbamoyl-2-(o-chlorophenyl)propanol sulfamate

3-N-methylcarbamoyl-2-(o-chlorophenyl)propanol sulfamate

Conditions
ConditionsYield
With pyridine In water; ethyl acetate; acetonitrile89%
2-((1S,2R)-6,6-dimethyl-norpinan-2-yl)-ethanol
266689-70-7

2-((1S,2R)-6,6-dimethyl-norpinan-2-yl)-ethanol

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

[(1S,2R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-yl]ethyl-sulfamate

[(1S,2R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-yl]ethyl-sulfamate

Conditions
ConditionsYield
In N,N-dimethyl acetamide at 0 - 20℃; for 3h;89%
sulphamoyl chloride
7778-42-9

sulphamoyl chloride

[(1R,2R,5R)-6,6-dimethylbicyclo[3.1.1]hept-2-yl]methyl-sulfamate
1145767-53-8

[(1R,2R,5R)-6,6-dimethylbicyclo[3.1.1]hept-2-yl]methyl-sulfamate

Conditions
ConditionsYield
In N,N-dimethyl acetamide at 0 - 20℃; for 3h;89%
sulphamoyl chloride
7778-42-9

sulphamoyl chloride

5-hexynyl p-toluenesulfonate
76911-01-8

5-hexynyl p-toluenesulfonate

8-(tosyloxy)oct-3-yn-1-sulfamate

8-(tosyloxy)oct-3-yn-1-sulfamate

Conditions
ConditionsYield
With 2,6-dimethylpyridine; formic acid In N,N-dimethyl acetamide; acetonitrile at 0 - 25℃; for 3.5h; Inert atmosphere;89%
tert-butyl 7-chloro-1-[5-[4-[[(1R,3R,4S)-3-(hydroxymethyl)-4-triisopropylsilyloxy-cyclopentyl]amino]pyrimidine-5-carbonyl]-2-methyl-3-thienyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate

tert-butyl 7-chloro-1-[5-[4-[[(1R,3R,4S)-3-(hydroxymethyl)-4-triisopropylsilyloxy-cyclopentyl]amino]pyrimidine-5-carbonyl]-2-methyl-3-thienyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate

sulphamoyl chloride
7778-42-9

sulphamoyl chloride

tert-butyl (1R)-7-chloro-1-[2-methyl-5-[4-[[(1R,3R,4S)-3-(sulfamoyloxymethyl)-4-triisopropylsilyloxy-cyclopentyl]amino]pyrimidine-5-carbonyl]-3-thienyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate

tert-butyl (1R)-7-chloro-1-[2-methyl-5-[4-[[(1R,3R,4S)-3-(sulfamoyloxymethyl)-4-triisopropylsilyloxy-cyclopentyl]amino]pyrimidine-5-carbonyl]-3-thienyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate

Conditions
ConditionsYield
With triethylamine In 2-methyltetrahydrofuran; N,N-dimethyl-formamide at 0℃; for 0.166667h;89%

7778-42-9Relevant articles and documents

Carbonic Anhydrase Glycoinhibitors belonging to the Aminoxysulfonamide Series

Ombouma, Joanna,Vullo, Daniella,Dumy, Pascal,Supuran, Claudiu T.,Winum, Jean-Yves

, p. 819 - 821 (2015)

Abstract A general approach for the synthesis of carbonic anhydrases glycoinhibitors belonging to an aminoxysulfonamide series is presented using a Ferrier sulfonamidoglycosylation reaction on glycals. All the compounds showed good in vitro inhibitory activity against four human carbonic anhydrase isoforms, with selectivity against the cytosolic (hCA II) vs the tumor associated (hCA IX and XII) enzymes.

Uracil-5-yl O-Sulfamate: An Illusive Radiosensitizer. Pitfalls in Modeling the Radiosensitizing Derivatives of Nucleobases

Arthur-Baidoo, Eugene,Chomicz-Mańka, Lidia,Denifl, Stephan,Falkiewicz, Karina,Kozak, Witold,Makurat, Samanta,Rak, Janusz,Rodrigues Costa, Mateus Salomao,Sikorski, Artur,Spisz, Paulina,Wyrzykowski, Dariusz,Zdrowowicz, Magdalena,Ziegler, Patrick

, p. 5600 - 5613 (2020)

Efficient radiotherapy requires the concomitant use of ionizing radiation (IR) and a radiosensitizer. In the present work uracil-5-yl O-sulfamate (SU) is tested against its radiosensitizing potential. The compound possesses appropriate dissociative electron attachment (DEA) characteristics calculated at the M06-2X/6-31++G(d,p) level. Crossed electron-molecular beam experiments in the gas phase demonstrate that SU undergoes efficient DEA processes, and the single C-O or S-O bond dissociations account for the majority of fragments induced by electron attachment. Most DEAs proceed already for electrons with kinetic energies of ~0 eV, which is supported by the exothermic thresholds calculated at the M06-2X/aug-cc-pVTZ level. However, in water solution under reductive conditions and physiological pH, SU does not undergo radiolysis, which demonstrates the crucial influence of aqueous environment on the radiosensitizing properties of modified nucleosides.

Oxidative Allene Amination for the Synthesis of Azetidin-3-ones

Burke, Eileen G.,Schomaker, Jennifer M.

, p. 12097 - 12101 (2015)

Regioselectivity in the aziridination of silyl-substituted homoallenic sulfamates is readily diverted to the distal double bond of the allene to yield endocyclic bicyclic methyleneaziridines with excellent stereocontrol. Subsequent reaction with electrophilic oxygen sources initiates facile rearrangement to densely functionalized, fused azetidin-3-ones in excellent d.r., effectively transferring the axial chirality of the allene to central chirality in the products. The steric nature of the silyl group dictates which of the two rings of the fused azetidin-3-one will undergo further functionalization, providing an additional element of diversity for the preparation of enantioenriched azetidine scaffolds with potential biological activity.

Novel steroid sulfatase inhibitors based on N-thiophosphorylated 3-(4-aminophenyl)-coumarin-7-O-sulfamates

Da?ko, Mateusz,Demkowicz, Sebastian,Biernacki, Karol,Harrous, Amira,Rachon, Janusz,Kozak, Witold,Martyna, Aleksandra,Mas?yk, Maciej,Kubiński, Konrad,Boguszewska-Czubara, Anna

, p. 857 - 866 (2019)

In the present work, we described convenient methods for the synthesis of N-thiophosphorylated 3-(4-aminophenyl)-coumarin-7-O-sulfamates as steroid sulfatase (STS) inhibitors. To design the structures of the potential STS inhibitors, molecular modeling techniques were used. A computational docking method was used to determine the binding modes of the synthesized inhibitors as well as to identify potential interactions between specified functional groups on the inhibitors and the amino acid residues present in the active site of the enzyme. The inhibitory activities of the synthesized compounds were tested in an enzymatic assay with STS isolated from a human placenta. Within the set of newly synthesized compounds, 9e demonstrated the highest inhibitory activity in the enzymatic assay with an IC50 value of 0.201 μM (the IC50 value of 667-COUMATE in the same test was 0.062 μM). Furthermore, we tried to verify if the obtained STS inhibitors are able to pass through the cellular membrane effectively in cell line experiments. In the course of our study, we determined the STS activity in the MCF-7 cell line after incubation in the presence of the inhibitors (at 100 nM concentration). For this evaluation, we included newly synthesized compounds 9a-g and their N-phosphorylated analogs 6a-h, whose synthesis has been previously described. We found that the lowest STS activities were measured in the presence of N-phosphorylated derivatives 6e (0.1% of STS activity) and 6f (0.2% of STS activity). The measured STS activity in the presence of 667-COUMATE (used as a reference) was 0.1%. Moreover, at concentrations up to 1 μM, the most active compounds (6e, 6f, 9b, and 9e) did not exert any toxic effects on zebrafish embryos.

Synthesis of 7-benzylguanosine cap-analogue conjugates for eIF4E targeted degradation

Kaur, Tanpreet,Menon, Arya,Garner, Amanda L.

, p. 339 - 350 (2019)

Eukaryotic translation initiation factor 4E (eIF4E) is a key player in the initiation of cap-dependent translation through recognition of the m7GpppX cap at the 5’ terminus of coding mRNAs. As eIF4E overexpression has been observed in a number of human diseases, most notably cancer, targeting this oncogenic translation initiation factor has emerged as a promising strategy for the development of novel anti-cancer therapeutics. Toward this end, in the present study, we have rationally designed a series of Bn7GxP-based PROTACs for the targeted degradation of eIF4E. Herein we describe our synthetic efforts, in addition to biochemical and cellular characterization of these compounds.

Lewis Base-Br?nsted Acid Co-catalyzed Morita-Baylis-Hillman Reaction of Cyclic Sulfamidate Imines

García Manche?o, Olga,Khassenova, Gaukhar

, p. 2752 - 2755 (2021)

A Lewis base-Br?nsted acid co-catalyzed Morita-Baylis-Hillman reaction of cyclic sulfamidate imines with acrylate-type Michael acceptors has been developed. The combination of equimolecular catalytic amounts of DABCO and acetic acid proved highly efficient and tolerated well a wide range of Michael acceptors and substituted 6-membered ring sulfamidate imines, as well as a sultam derivative. The reaction provides a straightforward access to sulfamidates bearing α,β-unsaturated chains, which allows for the further functionalization of the products. Moreover, the robustness and applicability of the method was demonstrated by performing a gram scale reaction and further functionalization of the MBH-adducts.

Gold(I)-Catalyzed Intramolecular Dehydrative Amination of Sulfamate Esters Tethered to Allylic Alcohols: A Strategy for the Synthesis of Cyclic Sulfamidates

Park, Yunjeong,Lee, Ji Sun,Ryu, Jae-Sang

supporting information, p. 2183 - 2188 (2021/03/15)

An efficient synthesis protocol for cyclic sulfamidates has been developed via catalytic intramolecular cyclizations of sulfamate esters tethered to allylic alcohols. The reactions proceed smoothly at room temperature in the presence of (IPr)AuCl (5 mol%) and AgBF4 (5 mol%). This protocol features good to excellent yields, high selectivity, broad substrate scope, and mild reaction conditions. This method is also applicable to the synthesis of a seven-membered sulfamidate. (Figure presented.).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7778-42-9